BRANCH RETINAL VEIN OCCLUSION

Clinical trials for BRANCH RETINAL VEIN OCCLUSION explained in plain language.

Never miss a new study

Get alerted when new BRANCH RETINAL VEIN OCCLUSION trials appear

Sign up with your email to follow new studies for BRANCH RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New eye drug challenge: can it beat the standard for saving sight?

Disease control Completed

This study tested if a new eye injection called 601 works as well as or better than the standard drug (ranibizumab) for treating vision loss caused by fluid buildup from a blocked retinal vein (BRVO). 351 adults with this condition received monthly injections of one of the two dr…

Matched conditions: BRANCH RETINAL VEIN OCCLUSION

Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

BRANCH RETINAL VEIN OCCLUSION

Get alerted when new BRANCH RETINAL VEIN OCCLUSION trials appear

New eye drug challenge: can it beat the standard for saving sight?